Lanreotide Pep-LNP

Name: Lanreotide Pep-LNP
SKU: TDLD-0126-LD110
Rating: 5 (1 reviews)

Cat. No.: TDLD-0126-LD110

Lanreotide Pep-LNP

Lanreotide Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) for targeted delivery of therapeutic cargoes. Featuring Lanreotide peptide, it binds somatostatin receptors (SSTR) overexpressed in tumors, enabling active targeting, with LNP enhancing stability and circulation. Applications include developing targeted tumor therapeutics and studying SSTR-mediated delivery. Please note that this product is intended for research purposes only.

Inquiry

SPECIFIC INQUIRY

Payload:

Modification:

Lipid Formulation:

Dye:

Concentration:

Quantity:

Clear All Inquiry

For Research Use Only. Not for Diagnostic or Treatment Applications.

Payload Type	mRNA
Payload	Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others
Capping	Cap 1
Modification	Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other

Module Type	Peptide
Targeting Module	Lanreotide Peptide

Target	Somatostatin receptors (SSTR)
Lipid Formulation	DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other
Dye	Unlabeled; DiR; DiD; DiO; DiI; Other
Application	Control; Targeted Delivery; Gene Therapy
Format	Liquid
Concentration	0.1 mg/mL; 0.2 mg/mL; Other (Please Specify)

Size	65-120 nm
PDI	< 0.2
Zeta	± 20.0 mV
Encapsulate Efficiency	>90%

Shipping	Dry Ice
Storage	Store at -80°C